NCT00505245 New Assessment System in Measuring Symptom Distress in Cancer Patients
| NCT ID | NCT00505245 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Caregiver |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,500 participants |
| Start Date | 1999-04-13 |
| Primary Completion | 2031-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,500 participants in total. It began in 1999-04-13 with a primary completion date of 2031-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in patients due to cancer and its treatment and how the symptoms impact quality of life.
Eligibility Criteria
Inclusion Criteria: * NORMAL SAMPLES: Community dwelling adults 18 years of age or older * PATIENT SAMPLES: Inpatients and outpatients 18 years of age or older, being followed at UT MD Anderson * EXPERT PANEL PROFESSIONAL PARTICIPANTS: Physician or other healthcare provider with at least 5 years of experience caring for patients with the disease and/or treatment of interest, at least one publication in the last 5 years dealing with the disease and/or treatment of interest (physician only), ability to speak and read English, consent to participate * EXPERT PANEL FAMILY CAREGIVERS PARTICIPANTS: Identification as a family caregiver by patient enrolled as expert panel participant with the disease and/or treatment of interest, 18 years of age or older, ability to speak and read English, consent to participate * EXPERT PANEL PATIENT PARTICIPANTS: Patient with identified family caregiver participating on Expert Panel, willingness to receive packet for expert panel participation Exclusion Criteria: * EXPERT PANEL PATIENT PARTICIPANTS: Patient with identified family caregiver participating on expert panel, willingness to receive packet for expert panel participation
Contact & Investigator
Xin Shelley Wang
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT00505245 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Caregiver. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00505245 currently recruiting?
Yes, NCT00505245 is actively recruiting participants. Contact the research team at xswang@mdanderson.org for enrollment information.
Where is the NCT00505245 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT00505245 clinical trial?
NCT00505245 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Xin Shelley Wang at M.D. Anderson Cancer Center. The trial plans to enroll 6,500 participants.